Daniel Sargent

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

D. Sargent, R. Goldberg, A. Grothey, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, Journal of the National Cancer Institute.

The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Susan Groshen, Larry Rubinstein, Lesley Seymour, 2010, Clinical Cancer Research.

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer

Yasuo Ohashi, Junichi Sakamoto, Tomasz Burzykowski, 2009 .

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.

Brian Bot, Greg Yothers, Qian Shi, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, European journal of cancer.

Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, Journal of the National Cancer Institute.

Optimism bias leads to inconclusive results-an empirical study.

Michael J. Schell, Iztok Hozo, Benjamin Djulbegovic, 2011, Journal of clinical epidemiology.

Issues in clinical trial design for tumor marker studies.

D. Sargent, C. Allegra, Daniel Sargent, 2002, Seminars in oncology.

Method for evaluating prediction models that apply the results of randomized trials to individual patients

Andrew J Vickers, Michael W Kattan, M. Kattan, 2007, Trials.